The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Target Validation, 2012Cannabinoid CB2 Receptors as a New Target for the Treatment of Disease Progression in Parkinson's Disease: Studies in LRRK2-Transgenic Pre-clinical Models
Objective/Rationale:
Cannabinoids provide neuroprotection in neurodegenerative disorders through the activation of specific targets within the so-called endocannabinoid system. The case... -
Resource: Utilizing DATATOP Biospecimens, 2012Circulating MicroRNAs: a New Paradigm for Parkinson's Disease Biomarker Discovery
Objective/Rationale:
We aim to assess miRNA stability and evaluate the potential of previously identified PD-predictive circulating miRNAs as progression biomarkers for PD using MJFF... -
MJFF Research Grant, 2012Pre-clinical Safety Study of LRRK2 Inhibitors
Objective/Rationale:
LRRK2 is well recognized as a potential central nervous system target for the treatment of Parkinson’s disease (PD). For development as possible therapeutic drugs...
-
Resource: Utilizing DATATOP Biospecimens, 2012Small-molecule PD Biomarkers: a Metabolomic Analysis
Objective/Rationale:
Based on our earlier findings that yielded several promising biomarkers, this metabolomic study of small-molecule biochemicals will investigate specimens from... -
Dyskinesia LEAPS, 2012Xenon Inhalation to Reduce L-DOPA-Induced Dyskinesia
Levodopa is the most effective drug to treat symptoms of Parkinson’s disease, however long-term use leads to disabling L-DOPA-induced dyskinesia (LID) in the vast majority of patients. NMDA receptor...
-
MJFF Research Grant, 2012Intrinsic Remodeling of the Fovea in Parkinson’s Disease
Promising Outcomes of Original Grant:
In the past we determined the part of the retina (the back of the eye) which needs to be measured for PD induced changes. We developed an equation which permits...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.